Brief: Exopharm Says Ian Dixon's Employment As CEO Expected To End In Early 2024

Entropy Neurodynamics

28/11/2023 24:59

Nov 28 (Reuters) - Exopharm Ltd  EX1.AX :
    * IAN DIXON EMPLOYMENT AS CEO IS EXPECTED TO END IN EARLY CY
24.
    * IS MINIMISING NON- ESSENTIAL COSTS
    * WORKING TO BRING POTENTIAL TRANSACTION TO SHAREHOLDERS AND
HAVE
COMPANY'S SHARES RECOMMENCE TRADING
    * DETERMINED THAT A FULL-TIME CEO ROLE WILL NOT BE REQUIRED
GOING
FORWARD
    * SEEKING A TRANSACTION THAT COULD RESULT IN A MATERIAL
CHANGE IN
COMPANY'S ACTIVITIES

Source text for Eikon:  ID:nASX93Dybs 
Further company coverage:  EX1.AX 

 ((Reuters.Briefs@thomsonreuters.com;))